(0.20%) 5 471.30 points
(0.20%) 39 198 points
(0.63%) 17 844 points
(1.86%) $83.06
(-4.08%) $2.50
(-0.09%) $2 337.50
(0.14%) $29.60
(-2.57%) $988.00
(-0.15%) $0.932
(-0.12%) $10.66
(0.00%) $0.791
(1.04%) $86.61
-3.57% $ 38.85
@ $39.50
Emitido: 1 jul 2024 @ 10:14
Retorno: -1.63%
Señal anterior: jun 28 - 15:51
Señal anterior:
Retorno: -2.43 %
Live Chart Being Loaded With Signals
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally...
Stats | |
---|---|
Volumen de hoy | 627 789 |
Volumen promedio | 1.60M |
Capitalización de mercado | 2.51B |
EPS | $-0.650 ( Q1 | 2024-05-02 ) |
Próxima fecha de ganancias | ( $-0.540 ) 2024-08-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-17.99 (Sector) 42.63 (Industry) 0 |
ATR14 | $2.09 (5.38%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-21 | Kyrillos Jean-claude | Sell | 0 | Common Stock |
2024-06-17 | Carpenter Rick | Buy | 406 | Common Stock |
2024-06-17 | Carpenter Rick | Sell | 145 | Common Stock |
2024-06-17 | Carpenter Rick | Sell | 406 | Restricted Stock Unit |
2024-06-17 | Cha Myoungil | Buy | 1 749 | Common Stock |
INSIDER POWER |
---|
61.46 |
Last 100 transactions |
Buy: 432 682 | Sell: 102 836 |
Volumen Correlación
Tandem Diabetes Care Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
DINT | 0.943 |
BNTC | 0.933 |
VCTR | 0.923 |
VITL | 0.911 |
FUTU | 0.908 |
AEYE | 0.907 |
PUI | 0.906 |
IBRX | 0.899 |
APOG | 0.899 |
LAUR | 0.897 |
10 Correlaciones Más Negativas | |
---|---|
SYPR | -0.919 |
TOI | -0.912 |
PEV | -0.908 |
SAGE | -0.908 |
OPOF | -0.901 |
APDN | -0.898 |
VRSN | -0.897 |
ASNS | -0.883 |
AEI | -0.88 |
APLS | -0.88 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Tandem Diabetes Care Inc Correlación - Moneda/Commodity
Tandem Diabetes Care Inc Finanzas
Annual | 2023 |
Ingresos: | $747.72M |
Beneficio Bruto: | $367.69M (49.17 %) |
EPS: | $-3.43 |
FY | 2023 |
Ingresos: | $747.72M |
Beneficio Bruto: | $367.69M (49.17 %) |
EPS: | $-3.43 |
FY | 2022 |
Ingresos: | $801.22M |
Beneficio Bruto: | $412.99M (51.54 %) |
EPS: | $-1.470 |
FY | 2021 |
Ingresos: | $702.80M |
Beneficio Bruto: | $376.22M (53.53 %) |
EPS: | $0.260 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Tandem Diabetes Care Inc
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico